Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C21H35N3 |
| Molecular Weight | 329.5227 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCN1CCN(CC1)C(=NCC(C)C)C2=CC=CC=C2
InChI
InChIKey=WRNQYBXJRPAGNS-UHFFFAOYSA-N
InChI=1S/C21H35N3/c1-4-5-6-10-13-23-14-16-24(17-15-23)21(22-18-19(2)3)20-11-8-7-9-12-20/h7-9,11-12,19H,4-6,10,13-18H2,1-3H3
| Molecular Formula | C21H35N3 |
| Molecular Weight | 329.5227 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Bucainide is a potent cardiac depressant and antiarrhythmic agent. The antiarrhythmic effect was demonstrated in the following animal models: mouse chloroform-induced ventricular arrhythmias, refractory period prolongation in guinea pig isolated atria, aconitine-induced atrial arrhythmias in the dog, ventricular arrhythmias following coronary artery ligation in the dog, and ouabain-induced ventricular tachyarrhythmias in the dog. The drug also possesses local anesthetic effects and is a weak central nervous system depressant. Studies with the radiolabeled drug in rats and dogs also demonstrated the drug's large volume of distribution, and its initial rapid disappearance from the blood. Tissue distribution studies in the rat after administration of the radiolabeled drug showed that bucainide is rapidly taken up by the tissues.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:22:24 GMT 2025
by
admin
on
Mon Mar 31 18:22:24 GMT 2025
|
| Record UNII |
F0D4M5RASG
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C47793
Created by
admin on Mon Mar 31 18:22:24 GMT 2025 , Edited by admin on Mon Mar 31 18:22:24 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
51481-62-0
Created by
admin on Mon Mar 31 18:22:24 GMT 2025 , Edited by admin on Mon Mar 31 18:22:24 GMT 2025
|
PRIMARY | |||
|
DTXSID20866201
Created by
admin on Mon Mar 31 18:22:24 GMT 2025 , Edited by admin on Mon Mar 31 18:22:24 GMT 2025
|
PRIMARY | |||
|
SUB05941MIG
Created by
admin on Mon Mar 31 18:22:24 GMT 2025 , Edited by admin on Mon Mar 31 18:22:24 GMT 2025
|
PRIMARY | |||
|
100000085862
Created by
admin on Mon Mar 31 18:22:24 GMT 2025 , Edited by admin on Mon Mar 31 18:22:24 GMT 2025
|
PRIMARY | |||
|
3969
Created by
admin on Mon Mar 31 18:22:24 GMT 2025 , Edited by admin on Mon Mar 31 18:22:24 GMT 2025
|
PRIMARY | |||
|
CHEMBL2110888
Created by
admin on Mon Mar 31 18:22:24 GMT 2025 , Edited by admin on Mon Mar 31 18:22:24 GMT 2025
|
PRIMARY | |||
|
F0D4M5RASG
Created by
admin on Mon Mar 31 18:22:24 GMT 2025 , Edited by admin on Mon Mar 31 18:22:24 GMT 2025
|
PRIMARY | |||
|
C77978
Created by
admin on Mon Mar 31 18:22:24 GMT 2025 , Edited by admin on Mon Mar 31 18:22:24 GMT 2025
|
PRIMARY | |||
|
40026
Created by
admin on Mon Mar 31 18:22:24 GMT 2025 , Edited by admin on Mon Mar 31 18:22:24 GMT 2025
|
PRIMARY | |||
|
C019280
Created by
admin on Mon Mar 31 18:22:24 GMT 2025 , Edited by admin on Mon Mar 31 18:22:24 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |